• LAST PRICE
    4.4900
  • TODAY'S CHANGE (%)
    Trending Down-0.0100 (-0.2222%)
  • Bid / Lots
    4.4800/ 3
  • Ask / Lots
    4.4900/ 6
  • Open / Previous Close
    4.4600 / 4.5000
  • Day Range
    Low 4.3900
    High 4.7400
  • 52 Week Range
    Low 3.6100
    High 23.9200
  • Volume
    555,829
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 4.5
TimeVolumeBMEA
09:32 ET80794.52
09:34 ET19304.467
09:36 ET174794.59
09:38 ET4004.6
09:39 ET239474.6
09:43 ET11584.6575
09:45 ET31334.55
09:48 ET12004.58
09:50 ET117104.6371
09:52 ET38774.615
09:54 ET2174.6224
09:56 ET29004.64
09:57 ET115664.69
09:59 ET76694.67
10:01 ET13054.67
10:03 ET35284.64
10:06 ET13994.63
10:08 ET23004.66
10:10 ET8534.66
10:12 ET37614.64
10:14 ET4004.6351
10:15 ET36214.63
10:17 ET10154.65
10:19 ET7504.66
10:21 ET21534.66
10:24 ET216034.67
10:26 ET69554.7
10:28 ET22034.695
10:30 ET7614.7
10:32 ET42984.705
10:33 ET93974.73
10:35 ET32404.71
10:37 ET24754.7
10:39 ET47614.69
10:42 ET81214.66
10:44 ET87734.67
10:46 ET10004.665
10:48 ET8004.69
10:50 ET8064.68
10:51 ET7004.7
10:53 ET7004.715
10:55 ET16004.71
10:57 ET16124.71
11:00 ET21374.7
11:02 ET13004.7014
11:04 ET1004.72
11:06 ET2004.71
11:08 ET5004.71
11:09 ET2204.71
11:11 ET4004.72
11:13 ET29004.7
11:15 ET50794.68
11:18 ET8004.68
11:20 ET7004.6875
11:22 ET14004.695
11:24 ET54574.67
11:27 ET18854.66
11:29 ET29004.64
11:31 ET28254.63
11:33 ET7754.65
11:36 ET16354.63
11:38 ET17004.62
11:40 ET9004.62
11:42 ET23204.62
11:44 ET2004.62
11:45 ET1004.62
11:47 ET1004.63
11:49 ET10004.63
11:51 ET72524.61
11:58 ET1004.61
12:00 ET4004.61
12:02 ET1004.61
12:03 ET6004.62
12:05 ET5194.62
12:07 ET3004.625
12:09 ET31044.59
12:12 ET19274.5883
12:14 ET17004.57
12:16 ET23374.56
12:18 ET9004.55
12:20 ET6004.55
12:21 ET20264.54
12:23 ET46744.52
12:25 ET2004.51
12:27 ET1004.52
12:30 ET5994.52
12:32 ET19704.5284
12:34 ET7004.52
12:36 ET29504.52
12:38 ET10004.51
12:39 ET19454.52
12:41 ET7004.53
12:43 ET22334.52
12:45 ET19944.515
12:48 ET25984.525
12:50 ET9004.515
12:54 ET187294.495
12:56 ET51934.505
12:57 ET62554.53
12:59 ET13004.52
01:01 ET147434.5476
01:03 ET22524.54
01:06 ET13574.55
01:08 ET2004.54
01:10 ET2004.53
01:12 ET15214.54
01:14 ET101244.52
01:15 ET1004.53
01:19 ET6594.5395
01:21 ET3004.54
01:24 ET22994.53
01:26 ET16004.53
01:28 ET2004.52
01:30 ET27824.52
01:32 ET5004.51
01:33 ET2004.5
01:35 ET2004.5
01:39 ET8004.49
01:42 ET17504.48
01:44 ET30304.465
01:46 ET10004.4699
01:48 ET21734.46
01:50 ET23644.46
01:51 ET6004.465
01:53 ET27734.47
01:55 ET5004.47
01:57 ET17114.46
02:02 ET2004.46
02:06 ET49924.459
02:08 ET51254.46
02:09 ET69524.455
02:11 ET20004.455
02:13 ET42004.45
02:15 ET3004.45
02:18 ET54884.46
02:20 ET2004.45
02:22 ET43614.42
02:24 ET144524.42
02:26 ET1004.42
02:27 ET25944.42
02:29 ET78664.4102
02:31 ET2004.41
02:33 ET65844.405
02:36 ET23004.405
02:38 ET37304.4
02:40 ET83094.4
02:42 ET35904.4
02:44 ET1004.405
02:45 ET6004.4
02:47 ET26324.395
02:49 ET25574.435
02:51 ET18754.4388
02:54 ET31004.43
02:58 ET40014.5
03:00 ET7044.495
03:02 ET20174.4874
03:03 ET16144.49
03:05 ET5004.49
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBMEA
Biomea Fusion Inc
161.8M
-1.3x
---
United StatesACHV
Achieve Life Sciences Inc
161.4M
-3.7x
---
United StatesVTYX
Ventyx Biosciences Inc
162.9M
-0.7x
---
United StatesFBLG
Fibrobiologics Inc
163.3M
-4.2x
---
United StatesXBIT
XBiotech Inc
156.6M
-5.2x
---
United StatesOTLK
Outlook Therapeutics Inc
172.7M
-0.6x
---
As of 2024-07-01

Company Information

Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).

Contact Information

Headquarters
900 Middlefield Road, 4Th FloorREDWOOD CITY, CA, United States 94063
Phone
650-980-9099
Fax
302-655-5049

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Thomas Butler
President, Co-Founder, Chief Operating Officer, Director
Rainer Erdtmann
Chief Financial Officer
Franco Valle
Chief Medical Officer
Juan Fras
Independent Director
Eric Aguiar

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$161.8M
Revenue (TTM)
$0.00
Shares Outstanding
35.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-3.57
Book Value
$4.72
P/E Ratio
-1.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.